VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan

首圖 ST. GALLEN, Switzerland — (BUSINESS WIRE) — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that Japan』s Ministry of Health and Labor Welfare (MHLW) has granted its part…


發佈留言